Trial Profile
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Endostatin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 06 Aug 2015 New trial record